Eco R1 Capital, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$4.91 - $14.7 $2.21 Million - $6.61 Million	-449,338 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.77 - $15.66 $5.97 Million - $9.56 Million	-610,705 Reduced 57.61%	449,338 $6.7 Million
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $728,840 - $912,000	-76,000 Reduced 6.69%	1,060,043 $10.9 Million
Q2 2019 Aug 14, 2019	SELL	$9.54 - $14.96 $4.38 Million - $6.88 Million	-459,600 Reduced 28.8%	1,136,043 $12 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $4.8 Million - $6.9 Million	556,143 Added 53.5%	1,595,643 $16.2 Million
Q2 2018 Aug 14, 2018	BUY	$8.3 - $16.8 $8.63 Million - $17.5 Million	1,039,500 New	1,039,500 $12.7 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.